Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| $223K |
| -3.0% |
| Open the original filing on SEC.gov |
| Nov 10 | AMLX | Amylyx Pharmaceuticals,… | SSELL◷ | 12,800 | $30.32 | $388.1K | -5.1% | Open the original filing on SEC.gov |
| Nov 10 | AMLX | Amylyx Pharmaceuticals,… | MEXER◷ | 20,000 | $6.88 | $137.6K | +8.6% | Open the original filing on SEC.gov |
| Nov 9 | AMLX | Amylyx Pharmaceuticals,… | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 9 | AMLX | Amylyx Pharmaceuticals,… | SSELL◷ | 12,300 | $30.11 | $370.4K | -5.0% | Open the original filing on SEC.gov |
| Nov 9 | AMLX | Amylyx Pharmaceuticals,… | SSELL◷ | 7,700 | $29.39 | $226.3K | -3.0% | Open the original filing on SEC.gov |
| Nov 9 | AMLX | Amylyx Pharmaceuticals,… | MEXER◷ | 20,000 | $6.88 | $137.6K | +8.6% | Open the original filing on SEC.gov |
| Sep 10 | AMLX | Amylyx Pharmaceuticals,… | SSELL | 1,042 | $33.23 | $34.6K | -0.4% | Open the original filing on SEC.gov |
| Sep 10 | AMLX | Amylyx Pharmaceuticals,… | SSELL | 9,768 | $32.27 | $315.2K | -4.0% | Open the original filing on SEC.gov |
| Aug 18 | AMLX | Amylyx Pharmaceuticals,… | AGRANT | 22,807 | — | — | +10.3% | Open the original filing on SEC.gov |
| Mar 5 | AMLX | Amylyx Pharmaceuticals,… | AGRANT◆ | 143,985 | — | — | — | Open the original filing on SEC.gov |
| Mar 5 | AMLX | Amylyx Pharmaceuticals,… | AGRANT | 95,990 | — | — | +58.0% | Open the original filing on SEC.gov |
| Mar 2 | AMLX | Amylyx Pharmaceuticals,… | SSELL | 7,909 | $14.52 | $114.9K | -4.6% | Open the original filing on SEC.gov |
| Feb 2 | AMLX | Amylyx Pharmaceuticals,… | SSELL | 3,557 | $14.65 | $52.1K | -2.0% | Open the original filing on SEC.gov |
| Jan 6 | AMLX | Amylyx Pharmaceuticals,… | SSELL | 3,326 | $11.11 | $37K | -1.8% | Open the original filing on SEC.gov |
| Sep 30, 2025 | AMLX | Amylyx Pharmaceuticals,… | SSELL | 10,558 | $14.65 | $154.7K | -3.6% | Open the original filing on SEC.gov |
| Jul 31, 2025 | SAGE | Sage Therapeutics, Inc. | DTOISS◆ | 21,500 | — | — | — | Open the original filing on SEC.gov |
| Jul 31, 2025 | SAGE | Sage Therapeutics, Inc. | DTOISS◆ | 19,154 | — | — | — | Open the original filing on SEC.gov |
| Jul 31, 2025 | SAGE | Sage Therapeutics, Inc. | UTENDR | 2,845 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 11, 2025 | SAGE | Sage Therapeutics, Inc. | AGRANT◆ | 21,500 | — | — | — | Open the original filing on SEC.gov |